Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 901–1,000 of 1,000
Dégénérescence maculaire liée à l’âge et génétique : données actuelles
Fajnkuchen, F., & Cohen, S. Y. (2008) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(08)75469-x · Cited by 5
Mutation screen of β-crystallin genes in 274 patients with age-related macular degeneration
Sturgill, G. M., Bala, E., Yaniglos, S. S., Peachey, N. S., & Hagstrom, S. A. (2010) · Ophthalmic Genetics · doi:10.3109/13816810.2010.486774 · Cited by 3
The Eye as a Target Organ for Stem Cell Therapy
Fields, M. A., Hwang, J. C., Gong, J., Cai, H., & Priore, L. V. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5493-9_1 · Cited by 3
Essential Fatty Acids and Visual Dysfunction
Vingrys, A. J., & Weymouth, A. E. (2007) · Food science and technology · doi:10.1201/9781420006902.ch43 · Cited by 3
The use of the vaccinia virus complement control protein (VCP) in the rat retina
Fernando, N., Natoli, R., Racic, T., Wooff, Y., Provis, J. M., & Valter, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193740 · Cited by 3
Membranoproliferative Glomerulonephritis
Licht, C. P. B., & Mengel, M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04883-5.50023-4 · Cited by 3
Li, Y., Fu, J., Liu, J., Feng, H., & Chen, X. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/3787567 · Cited by 4
Genetics of Age-Related Macular Degeneration
Zavala, R. A., Hicks, P. M., Lillvis, J. H., Zhang, C., Farkas, M. H., Owen, L. A., & DeAngelis, M. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_110 · Cited by 3
Thoreson, W. B., & Margalit, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05127-8 · Cited by 3
Complement: Deficiency Diseases
Blom, A. M. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0002154.pub2 · Cited by 3
Farrer, L. A., & DeAngelis, M. M. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.10.07 · Cited by 3
“Robust AMD associations with common and/or rare variants in CFH and other complement pathway genes including C2/CFB (19), C3 (9,10), C9 (20), CFI (13,21), and VTN (14) suggested that complement inhibition might be a good therapeutic option.”
BackgroundThe Role of Inflammation in Age-Related Macular Degeneration
Harris, J. M., & Wu, D. M. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000578 · Cited by 2
Çalışkan, B., & Demir, Y. (2026) · Current Eye Research · doi:10.1080/02713683.2026.2664597 · Cited by 2
Revisiting retinal and macular degeneration in the genomics era
Swaroop, A., & Roska, B. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00960-4 · Cited by 3
“Candidate gene approaches led to identification of additional complement genes 10,162,163 , and the complement pathway quickly acquired prominence for its role in AMD pathogenesis 164 and as a target for therapy development 165 .”
Overview and definition of age-related macular degeneration
Li, W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822061-0.00004-9 · Cited by 3
Supanji, S., Perdamaian, A. B. I., Anindita, D. A., Widayanti, T. W., Wardhana, F. S., Sasongko, M. B., Prayogo, M. E., Agni, A. N., & Oka, C. (2021) · BIO Web of Conferences · doi:10.1051/bioconf/20214106001 · Cited by 2
Shariat, M., Heydrzadeh, M., Abolhassani, H., Bemanian, M. H., & Yazdani, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821028-4.00011-7 · Cited by 3
The role of complement factor I rare genetic variants in age related macular degeneration in Finland
Andreadi, A., Hallam, T. M., Brocklebank, V., Sharp, S. J., Walsh, P. R., Southerington, T., Hautalahti, M., STEEL, D. H., Lotery, A. J., Harris, C. L., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae165 · Cited by 2
Omori, T., Machida, T., Ishida, Y., Sekiryu, T., & Sekine, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1566018 · Cited by 2
Alfonso‐González, L., Vega, M. C., & Fernández, F. J. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70054 · Cited by 2
“FH, C3, FB and FD in the AP and TP are all highly relevant, in agreement with the known physiological relevance of these proteins, whose alterations underlie the origin of complement-associated diseases (Barratt & Weitz, 2021; Gold et al., 2006; Haines et al., 2005; Noris & Remuzzi, 2015).”
Thoreson, W. B. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_11 · Cited by 2
Younger Siblings, C-Reactive Protein, and Risk of Age-Related Macular Degeneration
Cohn, A., Busija, L., Robman, L. D., Dimitrov, P. N., Varsamidis, M., Lim, L. L., Baird, P. N., & Guymer, R. H. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws332 · Cited by 2
AMD: Epidemiology and Risk Factors
Khan, J. C. (2013) · InTech eBooks · doi:10.5772/55234 · Cited by 2
Iwata, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-71767-8_18 · Cited by 3
Oxidative Stress and Systemic Changes in Age-Related Macular Degeneration
Brantley, M. A., Osborn, M. P., Cai, J., & Sternberg, P. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_18 · Cited by 2
Macular Degeneration: Risk Factors for Progression
Wiggs, J. L. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.9.1264 · Cited by 2
WITHDRAWN: Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.011 · Cited by 2
Lifestyle and age-related macular degeneration
Wickremasinghe, S., Chong, E. W. T., & Guymer, R. H. (2009) · Expert Review of Ophthalmology · doi:10.1586/17469899.4.1.79 · Cited by 2
Inflammation in Age-Related Macular Degeneration: What is the Evidence?
Xu, H., & Forrester, J. V. (2008) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-69459-5_7 · Cited by 4
“Other genetic studies also revealed replicable, but smaller, associations of several other genes, including complement factor B (CFB) [12, 13], complement C2 [ 12 , 13], C3 [14], IL-8 [15], CX3CR1 [16], TLR4 [17] and HLA class I and HLA class II [18] with AMD.”
ResultMolecular Genetics of the Major Histocompatibility Complex Class III Region
Campbell, R. D., Thomson, W., & Morley, B. J. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558848-00219 · Cited by 2
Analysis of copy number variation at DMBT1 and age-related macular degeneration
Polley, S., Cipriani, V., Khan, J. C., Shahid, H., Moore, A. T., Yates, J. R. W., & Hollox, E. J. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0311-5 · Cited by 3
“In addition to the identification of a strong genetic association between AMD and the RCA region, variation within several other complement genes such as complement factor B (CFB)/complement 2 (C2) [21], complement 3 (C3) [22] and complement factor I (CFI) [23] has been found to be associated with AMD.”
BackgroundHuman Gene Mapping and Disease Gene Identification
Nussbaum, R. L., McInnes, R. R., Willard, H. F., & Hamosh, A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3080-5.50012-2 · Cited by 2
Genetics of Age-Related Maculopathy
Fafowora, O. F., & Gorin, M. B. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0037 · Cited by 3
Inflammatory Response and Mediators in Retinal Injury
Chan, C., & Smith, W. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00025-4 · Cited by 3
Novel treatments and genetics of age-related macular degeneration-a narrative review
Arabi, A., & Shahraki, T. (2021) · Annals of Eye Science · doi:10.21037/aes-21-14 · Cited by 2
“Other frequently detected polymorphisms in AMD complement-related genes are C3, C2/CFB, CFI, C7, and SERPING (17-21).”
BackgroundFritsche, L. G., Friedrich, U., & Wxeber, B. H. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-22107-1_2 · Cited by 2
Thoreson, W. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_5 · Cited by 3
Oxidative Modifications as Triggers of AMD Pathology
Crabb, J. W. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_3 · Cited by 2
Interaction Between Photoreceptors and RPEs
Yoshida, T., & Ohno‐Matsui, K. (2014) · Springer eBooks · doi:10.1007/978-4-431-54965-9_18 · Cited by 2
“In addition to CFH, polymorphisms in complement factor B (CFB), complement factor I (CFI), factor 2 (C2), and factor 3 (C3) genes have been reported as novel risk factors for AMD [76–78].”
BackgroundMalek, G., Jamison, J. A., Mace, B. E., Sullivan, P. M., & Rickman, C. B. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_18 · Cited by 2
Francis, P. J. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0023109 · Cited by 2
Browning, A. C. (2013) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 2
Statistical Methods and Analysis in Genome Wide Association Studies and Next- Generation Sequencing.
Chen, W. (2011) · Deep Blue (University of Michigan) · Cited by 3
Establishing a human cell-based model system for macular degeneration
Neiteler, A. (2019) · ERA · doi:10.7488/era/8 · Cited by 3
Hinnerskov, J. M. V., Nielsen, M. K., Thomsen, A. K., Steffensen, M. A., Honoré, B., Vorum, H., Nissen, M. H., & Sørensen, T. (2026) · Immunity & Ageing · doi:10.1186/s12979-026-00562-y · Cited by 1
Candidate Gene Association Studies in Stroke
Holliday, E. G., Oldmeadow, C. J., Maguire, J. M., & Attia, J. (2012) · Springer eBooks · doi:10.1007/978-0-85729-209-4_2 · Cited by 1
“Associations of these loci with AMD have now been con fi rmed by CGAS pooling and meta-analyses [ 64, 65 ] ; however, the associations are too weak to have been de fi nitively identi fi ed by GWAS at accepted signi fi cance levels in available sample sizes.”
BackgroundTherapeutic effects of ranibizumab in neovascular age-related macular degeneration
Ciulla, T. A. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.5.679 · Cited by 1
Ho, L., van Leeuwen, R., de Jong, P. T. V. M., Vingerling, J. R., & Klaver, C. C. W. (2011) · Springer eBooks · doi:10.1007/978-3-642-20870-6_1 · Cited by 2
Serotonin 5-HT1A Receptor Agonists in Oxidative Stress and Retinal Disease
Collier, R. J., Noronha, G., & Romano, C. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_22 · Cited by 1
Retinal Remodeling and Visual Prosthetics
Jones, B. W., Marc, R. E., & Watt, C. B. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0754-7_3 · Cited by 1
Current and future strategies for nonexudative age-related macular degeneration
Grisanti, S., Lüke, J., Lüeke, M., Rudolf, M., & Peters, S. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.11.26 · Cited by 1
VEGF inhibition: latest developments
McAvoy, C. E., & Chakravarthy, U. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.4.621 · Cited by 1
Genetic Basis of Age-related Macular Degeneration
Othman, M., Branham, K. E. H., & Heckenlively, J. R. (2011) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2011.04.02.119 · Cited by 1
Die altersabhängige Makuladegeneration — eine Übersicht
Steinberg, J., Uibel, S., Berndt, T., Müller, D., Quarcoo, D., & Groneberg, D. A. (2011) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/bf03345002 · Cited by 1
Epidemiology of Age-Related Macular Degeneration Early in the 21st Century
Wang, J. J., Mitchell, P., & Klein, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_2 · Cited by 1
Age-Related Macular Degeneration and Vision Impairment
Wright, C. B., & Ambati, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_16 · Cited by 1
Genetic Polymorphism in Proteins of the Complement System
Kim, H., Hwang, D., Han, J., Lee, H. K., Yang, W. J., Jin, J., Kim, K.-H., Kim, S. I., Yoo, D. K., Kim, S., et al. (2016) · Korean Journal of Transplantation · doi:10.4285/jkstn.2016.30.2.59 · Cited by 1
“rs12614, rs64153은 대립형질빈도가 각각 13∼19%, 9∼11% 정도이고, 보체 C2의 rs547154 단일염기다형성과 연관되어있다고 알려져 있으며, 역시 노인성 황반변성 발생을 저해하는 것으로 보 고되었다(32).”
Proteomic Biomarkers for Age-Related Macular Degeneration
Crabb, J. W. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0022 · Cited by 1
Textbook of Vitreoretinal Diseases and Surgery
Natarajan, S., Hussain, N., & Dabir, S. (2009) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10962 · Cited by 2
Genetic markers for age-related macular degeneration
Wong, C. W., & Cheng, C. (2014) · doi:10.2217/fmeb2013.13.255 · Cited by 3
Proteomics of Neurodegenerative Disorders of the Eye
Ramasamy, K., Krishnadas, R., Dharmalingam, K., & Jayapal, J. M. (2018) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-13-0884-0_32 · Cited by 1
Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases
Hogden, M. C., & Tsang, S. H. (2019) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-05222-5_3 · Cited by 2
Medikamentöse Therapieansätze für die nicht neovaskuläre AMD
Zeitz, O., Frentzel, D. P., Rübsam, A., Seibel, I., Riechardt, A. I., Brockmann, C., Meißner, F., & Joussen, A. M. (2019) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-0914-3183 · Cited by 1
“[16] Gold B, Merriam JE, Zernant J et al.”
BackgroundRoshanipour, N., Laleh, M. G., Bonyadi, M. J., Bonyadi, M. H. J., Soheilian, M., Javadzadeh, A., & Yaseri, M. (2020) · BMC Ophthalmology · doi:10.1186/s12886-020-01552-4 · Cited by 1
Genetics of Age-Related Macular Degeneration in Asia
Yamashiro, K. (2021) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-15-9184-6_6 · Cited by 1
The Contribution of Rare Allele and Junk Genome in AMD Pathogenesis
Sharma, K., Tyagi, R., Battu, P., Kumar, S., Sharma, N. K., & Anand, A. (2021) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-15-9184-6_7 · Cited by 1
Genetics of age-related macular degeneration
Li, W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822061-0.00001-3 · Cited by 2
Fleckenstein, M., Schmitz-Valckenberg, S., Sunness, J. S., & Holz, F. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-20870-6_8 · Cited by 2
Arrigo, A., & Bandello, F. M. (2022) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2022.16.1.30 · Cited by 1
Macular Degeneration, Geographic Atrophy, and Inherited Retinal Disorders
Gupta, A., Bansal, R., Sharma, A., & Kapil, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-7923-3_13 · Cited by 3
Pan, M., Yuan, X., Peng, J., Wu, R., & Chen, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-725 · Cited by 1
“Among these, C2 , a complement protein, has been linked to age-related macular degeneration and type 2 diabetes (22,23).”
Toward a Higher Fidelity Model of AMD
Raisler, B. J., Nozaki, M., Baffi, J., Hauswirth, W. W., & Ambati, J. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_21 · Cited by 1
“complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Magnusson et al., 2006), factor B (Gold et al., 2006), the LOC387715 locus (Rivera et al., 2005), HTRA1(Dewan et al., 2006; Yang et al., 2006), and complement component 2 ( Gold et al., 2006 ) have each been…”
BackgroundTimely translation of ophthalmic research into clinical practice
McCarty, C. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.098897 · Cited by 1
Steinbrugger, I., Haas, A., Renner, W., Mayer, M., Wedrich, A., El‐Shabrawi, Y., Werner, C. D., Schmut, O., & Weger, M. (2009) · Spektrum der Augenheilkunde · doi:10.1007/s00717-009-0355-4 · Cited by 1
Big DNA as a tool to dissect an age-related macular degeneration-associated haplotypePreprint
Laurent, J. M., Fu, X., German, S. V., Maurano, M. T., Zhang, K., & Boeke, J. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/461251 · Cited by 1
Zysset‐Burri, D. C., Keller, I., Berger, L., Largiadèr, C. R., Wittwer, M., Wolf, S., & Zinkernagel, M. S. (2019) · doi:10.21203/rs.2.18334/v1 · Cited by 1
“However, rs12614 (p = 0.0057) within the complement factor B (CFB) gene was inversely correlated with AMD in the cohort (Fisher’s exact test, Table 2). in the CFH1 gene.”
BackgroundInfluentialThe role of complement components C2 and C5a in HIV associated preeclampsia.
Govender, S. (2020) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
Singh, A. K. (2013) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/4380 · Cited by 1
Degeneração macular relacionada à idade: estudo dos fatores de risco em uma população brasileira
Rim, P. H. H. (2012) · doi:10.47749/t/unicamp.2012.853614 · Cited by 1
Dynamic changes in mRNA isoform usage during human retinal organoid developmentPreprint
Keuthan, C. J., Parthiban, S., Chang, Y.-Y., Shan, X., Chang, X., Yan, E., Cavalier, S., Timp, W., Hicks, S. C., & Zack, D. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.689062 · Cited by 1
Bazan, N. G., & Halabi, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_7
The genetic associations of rhegmatogenous retinal detachment and ectopia lentis
Chandra, A. (2014) · UCL Discovery (University College London)
Genetics of age-related maculopathy & Score statistics for X-linked quantitative trait loci
Jakobsdóttir, J. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Longville, B. A. C. (2009) · Murdoch University Research Portal
Kijlstra, A., Heij, E. C. L., Goezinne, F., & Hendrikse, F. (2008) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-69459-5_8
“The field of genetics in AMD was revolutionized with the discovery of an association between AMD and the complement pathway genes such as complement factor H (CFH), complement component 2 (C2) and the complement factor B (FB) [20, 27 , 31, 33, 56].”
BackgroundMarin‐Castaño, M. E., & Pons, M. (2011) · Wiley eBooks · doi:10.1002/9783527635320.ch14
Li, Y. (2015) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Biomarkers for Age-Related Macular Degeneration
Gu, J. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
New Perspectives in Geographic Atrophy Associated with AMD
Schmitz-Valckenberg, S., Fleckenstein, M., Scholl, H. P. N., & Holz, F. G. (2007) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-33672-3_8
Genetics of inherited retinal degeneration
Schindler, E. I. (2011) · doi:10.17077/etd.mq7ljcy9
Macular Degeneration—An Addendum
Barnstable, C. J., & Tombran‐Tink, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_25
Statistical Methods and Analysis in Next Generation Sequencing.
Zhan, X. (2014) · Deep Blue (University of Michigan)
When a Disease Gene is Not Really a Disease Gene
Glasscock, E., & Noebels, J. L. (2008) · Future Neurology · doi:10.2217/14796708.3.2.103
“Another study from 2006, which examined genetic risk factors in age-related macular degeneration (AMD), corroborates this idea of healthy epistasis, which is likely at work in many human diseases [11].”
BackgroundTillmann, S., Grasskamp, A. T., Wulf, M., Martis, L., Domani, M., & Sand, P. G. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt204
da Silva, A. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-03022010-092312 · Cited by 1
Age-related macular degeneration: histopathological and serum autoantibody studies
Cherepanoff, S. (2007) · The Sydney eScholarship Repository (The University of Sydney)
Genetic and modifiable risk factors for age-related macular degeneration
Wang, J. J. (2006) · Expert Review of Ophthalmology · doi:10.1586/17469899.1.2.181
Kim, J.-H. (2008) · Journal of Animal Science and Technology · doi:10.5187/jast.2008.50.6.753
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.